Although PD-1/PD-L1 expression level, microsatellite instability level, tumor mutation load, EBV, and other indicators significantly affect the efficacy of immunotherapy, these indicators cannot fulfill the criteria for accurate screening. This evidence concerns the gene CD274 and neoplasm.